News
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Poxel Announces the Publication of Two Preclinical Articles on X-Linked Adrenoleukodystrophy for PXL065 and PXL770
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Pharnext Appoints Antoine Gravelle as General Counsel
Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
Regulatory News:
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
izzi nutzt Verimatrix XTD und Streamkeeper zum Schutz seiner beliebten Medien-Apps und Endpunkte
Verimatrix (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass izzi , ein mexikanisches
izzi Taps Verimatrix XTD and Streamkeeper to Protect Its Popular Media Apps, Endpoint
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that izzi , a mexican
Bureau Veritas Acquires Advanced Testing Laboratory, a US Leader in Scientific Sourcing
Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North
Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA®
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
Pharnext: Findings on Symptoms Burden of Charcot-Marie-Tooth Disease Type 1A From the ‘Real-World’ Digital Lifestyle Study, CMT&Me, to be Presented at the ICNMD 2022
GEVELOT S.A.: weekly report of share buyback transactions June 27,2022
Transgene and BioInvent Announce Positive Progress for BT-001
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB
Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Poxel Announces Results from June 21, 2022 Ordinary Annual and Extraordinary General Meeting
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Mexikanisches Fintech albo setzt auf Verimatrix zur Bedrohungsabwehr
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), ein führender Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass albo, einer der am
Mexican Fintech albo Taps Verimatrix for Threat Defense
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that albo, one of Mexico’s
Pharnext Holds Shareholders Meeting and Appoints Dr. James Kuo to Renewed Board of Directors
Threat Defense-Technologie von Verimatrix mit Global Infosec Award 2022 ausgezeichnet
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass seine Lösung Verimatrix App
Verimatrix Threat Defense Technology Wins 2022 Global Infosec Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced Verimatrix App Shield, part of the
GEVELOT S.A.: Declaration of crossing the shareholding threshold 16 June 2022
Kaufman & Broad SA: OFFER RESERVED FOR EMPLOYEES KB SHARES 2022
GEVELOT S.A.: Implementation of a share buyback programme 15 June 2022
GEVELOT S.A.: PRESS RELEASE ANNUAL GENERAL MEETING 15 JUNE 2022